Holy Stone Healthcare Co., Ltd. (TPEX:4194)
Taiwan · Delayed Price · Currency is TWD 7.23
+0.04 (0.56%)
May 29, 2026, 1:45 PM CST
Holy Stone Healthcare Market Cap
Holy Stone Healthcare has a market cap or net worth of 1.06 billion as of May 29, 2026. Its market cap has decreased by -3.21% in one year.
Market Cap
1.06B
Enterprise Value
922.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.23
Market Cap Chart
Since December 13, 2013, Holy Stone Healthcare's market cap has decreased from 5.54B to 1.06B, a decrease of -80.97%. That is a compound annual growth rate of -12.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.06B | -6.10% |
| Dec 31, 2025 | 1.12B | -40.54% |
| Dec 31, 2024 | 1.89B | -21.47% |
| Dec 29, 2023 | 2.41B | -36.56% |
| Dec 30, 2022 | 3.79B | 20.29% |
| Dec 30, 2021 | 3.15B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.26B |
| Meribank Biotech | 1.18B |
| BiOptic | 1.17B |
| LabTurbo Biotech | 1.10B |
| Level Biotechnology | 1.09B |
| Lukas Biomedical | 1.05B |
| GeneReach Biotechnology | 1.02B |
| U-Neuron Biomedical | 1.00B |